Surgery Partners, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.3B | $3.1B | $2.7B | $2.5B | $2.2B |
| Operating expenses | $2.9B | $2.8B | $2.4B | $2.2B | $1.9B |
| Operating income | $389.5M | $348.8M | $328.0M | $345.2M | $302.2M |
| Income tax expense | $18.0M | $134.6M | -$300,000 | $23.3M | $10.5M |
| Net income | -$77.9M | -$168.1M | -$11.9M | -$54.6M | -$70.9M |
| Balance Sheet | |||||
| Cash and equivalents | $239.9M | $269.5M | $195.9M | $282.9M | $389.9M |
| Current assets | $1.2B | $1.1B | $895.0M | $921.0M | $946.1M |
| Total assets | $8.1B | $7.9B | $6.9B | $6.7B | $6.1B |
| Current liabilities | $615.5M | $624.4M | $523.0M | $493.4M | $536.8M |
| Stockholders' equity | $1.7B | $1.8B | $2.0B | $2.0B | $1.1B |
| Cash Flow Statement | |||||
| Cash from operations | $274.3M | $300.1M | $293.8M | $158.8M | $87.1M |
| Depreciation and amortization | $176.0M | $152.6M | $118.1M | $114.8M | $98.8M |
| Stock-based compensation | $14.8M | $33.3M | $17.7M | $18.4M | $17.4M |
| Capital expenditure | $78.7M | $90.4M | $88.8M | $80.6M | $57.6M |
| Free cash flow | $195.6M | $209.7M | $205.0M | $78.2M | $29.5M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 130.8M · Free float 83.6%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.